# Maze Therapeutics (MAZE) — Analyst Forecast

MAZE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/maze/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 13 | 0 | 0 | 13 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $46.00 | $63.50 | $110.00 | 4 |

Last price $27.48 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $110.00 |
| Sep 23, 2026 | Wedbush | Maintained | Outperform | $48.00 |
| Sep 23, 2026 | Citigroup | Initiated Coverage | Buy | $50.00 |
| Sep 22, 2026 | BTIG | Maintained | Buy | $46.00 |
| Aug 12, 2026 | BTIG | Maintained | Buy | $46.00 |
| Apr 14, 2026 | Truist Securities | Maintained | Buy | $64.00 |
| Mar 31, 2026 | JP Morgan | Maintained | Overweight | $58.00 |
| Mar 25, 2026 | HC Wainwright & Co. | Maintained | Buy | $110.00 |
| Mar 25, 2026 | BTIG | Maintained | Buy | $46.00 |
| Mar 18, 2026 | Truist Securities | Initiated Coverage | Buy | $68.00 |
| Mar 16, 2026 | Wedbush | Maintained | Outperform | $58.00 |
| Mar 10, 2026 | Mizuho | Initiated Coverage | Outperform | $97.00 |
| Mar 9, 2026 | BTIG | Maintained | Buy | $46.00 |
| Mar 4, 2026 | Guggenheim | Maintained | Buy | $58.00 |
| Jan 16, 2026 | BTIG | Maintained | Buy | $46.00 |
| Dec 4, 2025 | Wells Fargo | Initiated Coverage | Overweight | $55.00 |
| Dec 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $60.00 |
| Nov 7, 2025 | Wedbush | Maintained | Outperform | $36.00 |
| Sep 29, 2025 | JP Morgan | Maintained | Overweight | $37.00 |
| Sep 18, 2025 | HC Wainwright & Co. | Maintained | Buy | $50.00 |

## Frequently Asked Questions

### What is the price target for MAZE stock?

The average 12-month analyst price target for Maze Therapeutics (MAZE) is $63.50, with a high estimate of $110.00 and a low of $46.00, across 4 analysts.

### Is MAZE a buy, sell, or hold?

Analysts covering Maze Therapeutics currently average a Buy rating: 13 buy, 0 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for MAZE?

The average price target of $63.50 implies 131.08% upside from the last price of $27.48.

### What is the latest analyst rating on MAZE?

On Sep 24, 2026, HC Wainwright & Co. maintained Maze Therapeutics at Buy with a price target of $110.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).